Cargando…

Ektacytometry Analysis of Post-splenectomy Red Blood Cell Properties Identifies Cell Membrane Stability Test as a Novel Biomarker of Membrane Health in Hereditary Spherocytosis

Hereditary spherocytosis (HS) is the most common form of hereditary chronic hemolytic anemia. It is caused by mutations in red blood cell (RBC) membrane and cytoskeletal proteins, which compromise membrane integrity, leading to vesiculation. Eventually, this leads to entrapment of poorly deformable...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berrevoets, M. C., Bos, J., Huisjes, R., Merkx, T. H., van Oirschot, B. A., van Solinge, W. W., Verweij, J. W., Lindeboom, M. Y. A., van Beers, E. J., Bartels, M., van Wijk, R., Rab, M. A. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027126/ https://www.ncbi.nlm.nih.gov/pubmed/33841180 http://dx.doi.org/10.3389/fphys.2021.641384

Ejemplares similares

PI-04: OXYGEN GRADIENT EKTACYTOMETRY-DERIVED BIOMARKERS ARE ASSOCIATED WITH THE OCCURRENCE OF ACUTE COMPLICATIONS IN SICKLE CELL DISEASE
por: M., RAB, et al.
Publicado: (2022)

Comment on: Oxygen gradient ektacytometry does not predict pain in children with sickle cell anaemia
por: Sheehan, Vivien A., et al.
Publicado: (2022)

The Complexity of Genotype-Phenotype Correlations in Hereditary Spherocytosis: A Cohort of 95 Patients: Genotype-Phenotype Correlation in Hereditary Spherocytosis
por: van Vuren, Annelies, et al.
Publicado: (2019)

Metabolic Fingerprint in Hereditary Spherocytosis Correlates With Red Blood Cell Characteristics and Clinical Severity
por: van Dooijeweert, Birgit, et al.
Publicado: (2021)

Oxygen gradient ektacytometry‐derived biomarkers are associated with vaso‐occlusive crises and correlate with treatment response in sickle cell disease
por: Rab, Minke A. E., et al.
Publicado: (2020)

The fluid membrane determines mechanics of erythrocyte extracellular vesicles and is softened in hereditary spherocytosis
por: Vorselen, Daan, et al.
Publicado: (2018)

Density, heterogeneity and deformability of red cells as markers of clinical severity in hereditary spherocytosis
por: Huisjes, Rick, et al.
Publicado: (2020)

PI-02: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE
por: M., VAN DIJK, et al.
Publicado: (2022)

P1501: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE
por: van Dijk, M. J., et al.
Publicado: (2022)

5589320 FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE
por: van Dijk, M.J., et al.
Publicado: (2023)

Subtotal Splenectomy in Hereditary Spherocytosis - Advantages and Disadvantages
por: BICĂ, C., et al.
Publicado: (2016)

P1424: ONE-YEAR FOLLOW-UP OF A PHASE 2 STUDY OF MITAPIVAT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR THE TREATMENT OF SICKLE CELL DISEASE
por: van Dijk, Myrthe, et al.
Publicado: (2023)

P1492: PHARMACODYNAMIC EFFECTS OF AG-946, A HIGHLY POTENT NOVEL ACTIVATOR OF PYRUVATE KINASE, IN EX VIVO TREATMENT OF RED BLOOD CELLS FROM SICKLE CELL DISEASE PATIENTS
por: Rab, M., et al.
Publicado: (2022)

PI-05: PHARMACODYNAMIC EFFECTS OF AG-946, A HIGHLY POTENT NOVEL ACTIVATOR OF PYRUVATE KINASE, IN EX VIVO TREATMENT OF RED BLOOD CELLS FROM SICKLE CELL DISEASE PATIENTS
por: M., RAB, et al.
Publicado: (2022)

PB2248: CONCOMITANT HEREDITARY SPHEROCYTOSIS AND PYRUVATE KINASE DEFICIENCY IN A SPANISH FAMILY WITH CHRONIC HEMOLYTIC ANEMIA. CONTRIBUTION OF LASER EKTACYTOMETRY TO CLINICAL DIAGNOSIS
por: Vives Corrons, J.-L., et al.
Publicado: (2022)

Anaesthetic management of a case of hereditary spherocytosis for splenectomy and cholecystectomy
por: Chaithanya, Krishna, et al.
Publicado: (2014)

Topological Structures and Membrane Nanostructures of Erythrocytes after Splenectomy in Hereditary Spherocytosis Patients via Atomic Force Microscopy
por: LI, Ying, et al.
Publicado: (2016)

Concomitant Hereditary Spherocytosis and Pyruvate Kinase Deficiency in a Spanish Family with Chronic Hemolytic Anemia: Contribution of Laser Ektacytometry to Clinical Diagnosis
por: Vives Corrons, Joan-Lluis, et al.
Publicado: (2022)

AG-348 (mitapivat), an allosteric activator of red blood cell pyruvate kinase, increases enzymatic activity, protein stability, and adenosine triphosphate levels over a broad range of PKLR genotypes
por: Rab, Minke A.E., et al.
Publicado: (2020)

Splenectomy improves erythrocyte functionality in spherocytosis based on septin abundance, but not maturation defects
por: Cloos, Anne-Sophie, et al.
Publicado: (2023)

Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients
por: Rab, Minke A.E., et al.
Publicado: (2019)

Squeezing for Life – Properties of Red Blood Cell Deformability
por: Huisjes, Rick, et al.
Publicado: (2018)

Single Incision Laparoscopic Splenectomy in a 5-Year-Old With Hereditary Spherocytosis
por: Hansen, Erik N., et al.
Publicado: (2010)

Anesthetic management of a patient with hereditary spherocytosis for laparoscopic cholecystectomy and splenectomy
por: Bharne, Sidhesh, et al.
Publicado: (2012)

Abnormalities of erythrocyte membrane proteins in Korean patients with hereditary spherocytosis.
por: Lee, Y. K., et al.
Publicado: (2000)

P717: AG946, A PYRUVATE KINASE (PK) ACTIVATOR IMPROVES PK PROPERTIES AND RED BLOOD CELL (RBC) METABOLISM UPON EX VIVO TREATMENT OF RBCS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES
por: de Wilde, Jonathan, et al.
Publicado: (2023)

Untargeted metabolic profiling in dried blood spots identifies disease fingerprint for pyruvate kinase deficiency
por: van Dooijeweert, Birgit, et al.
Publicado: (2020)

Methodological aspects of the oxygenscan in sickle cell disease: A need for standardization
por: Rab, Minke A.E., et al.
Publicado: (2019)

Dried blood spot metabolomics reveals a metabolic fingerprint with diagnostic potential for Diamond Blackfan Anaemia
por: van Dooijeweert, Birgit, et al.
Publicado: (2021)

Evaluation of Collagen Membranes Coated with Testosterone and Alendronate to Improve Guided Bone Regeneration in Mandibular Bone Defects in Minipigs
por: van Oirschot, Bart A. J. A., et al.
Publicado: (2020)

Hereditary spherocytosis with successful splenectomy in a pregnant black South African lady: a case report
por: Elmezughi, Khaled, et al.
Publicado: (2019)

P1500: WHAT’S DRIVING RDW? IN-VITRO AND IN-SILICO EVIDENCE FOR OXIDATIVE STRESS
por: Joosse, Huibert-Jan, et al.
Publicado: (2023)

In-vitro and in-silico evidence for oxidative stress as drivers for RDW
por: Joosse, Huibert-Jan, et al.
Publicado: (2023)

P1550: NEW GENERATION EKTACYTOMETRY STUDY OF RED BLOOD CELLS RHEOLOGICAL PARAMETERS IN HEMOGLOBINOPATHIES
por: Krishnevskaya, E., et al.
Publicado: (2022)

Hereditary Spherocytosis
por: Huq, Sayeeda, et al.
Publicado: (2010)

P1481: SYSTEMATICALLY REDUCED RED CELL PHOSPHATIDYLSERINE FLIPPASE ACTIVITY IS SUFFICIENT TO INDUCE HEREDITARY HEMOLYTIC ANEMIA
por: van Dijk, Myrthe, et al.
Publicado: (2023)

A Comprehensive Analysis of the Erythropoietin-erythroferrone-hepcidin Pathway in Hereditary Hemolytic Anemias
por: van Vuren, Annelies J., et al.
Publicado: (2021)

Pulmonary arterial hypertension associated with hereditary spherocytosis and splenectomy in a patient with a mutation in the BMPR2 gene
por: Baloira, Adolfo, et al.
Publicado: (2016)

PB2509: RED BLOOD CELL PYRUVATE KINASE PROPERTIES IN SICKLE CELL DISEASE – OF MICE AND MEN
por: Traets, Marissa, et al.
Publicado: (2023)

Automated Oxygen Gradient Ektacytometry: A Novel Biomarker in Sickle Cell Anemia
por: Sadaf, Alina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5u3sae9gtfpl14jcf2arcfli7h